Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenon

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 6, 2013, Pages 878-882

  Shiraishi, Kouichi ^a   Yokoyama, Masayuki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Accelerated blood clearance phenomenon; Block copolymer; Drug targeting; Magnetic resonance imaging contrast agent; Polyethyleneglycol; Polymeric micelle

Indexed keywords

CONTRAST MEDIUM; DRUG CARRIER; LIPOSOME; MACROGOL; NANOSHELL; POLYMER; WATER;

ACCELERATED BLOOD CLEARANCE; BIOMEDICINE; CELL TRANSPORT; DRUG RESEARCH; DRUG TARGETING; FEASIBILITY STUDY; HYDROPHOBICITY; IMMUNE RESPONSE; MICELLIZATION; MOLECULAR WEIGHT; PLASMA CLEARANCE; REVIEW; SOLUBILITY; SYNTHESIS; THERANOSTICS;

DRUG CARRIERS; METABOLIC CLEARANCE RATE; MICELLES; POLYETHYLENE GLYCOLS;

EID: 84878859649     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00085     Document Type: Review

References (39)

1. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol., 2, 249-255 (2007).
2. Christian DA, Cai S, Garbuzenko OB, Harada T, Zajac AL, Minko T, Discher DE; DA. Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol. Pharm., 6, 1343-1352 (2009).
3. Yokoyama M. Block copolymers as drug carriers. Crit. Rev. Ther. Drug Carrier Syst., 9, 213-248 (1992).
4. Yokoyama M. Polymeric micelles for the targeting of hydrophobic drugs. Drug and pharmaceutical sciences. Vol. 148 polymeric drug delivery systems. (Kwon GS ed.) Taylor & Francis, Boca Raton, pp. 533-575 (2005).
5. Yokoyama M. Polymeric micelles as nano-sized drug carrier systems. Nanoparticles for pharmaceutical applications. (Domb AJ, Tabata Y, Ravi Kuman MNV, Farber S eds.) American Scientific Publishers, Stevenson Ranch, pp. 63-72 (2007).
6. Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert Opin. Drug Deliv., 7, 145-158 (2010).
7. Yokoyama M. Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors. J. Experimental and Clinical Medicine, 3, 151-158 (2011).
8. Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carrier Syst., 20, 357-403 (2003).
9. Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opin. Drug Deliv., 3, 139-162 (2006).
10. Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J. Pharm. Sci., 92, 1343-1355 (2003).
11. Bader H, Ringsdorf H, Schmidt B. Watersoluble polymers in medicine. Angew. Chem., 123/124, 457-485 (1984).
12. Pratten MK, Lloyd JB, Ringsdorf H. Micelle-forming block copolymers: Pinocytosis by macrophages and interaction with model membranes. Makromol. Chem., 186, 725-733 (1985).
13. Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y. Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. A new type of polymeric anticancer agent. Makromol. Chem., Rapid. Commun., 8, 431-435 (1987).
14. Yokoyama M, Inoue S, Kataoka K, Yui N, Okano T, Sakurai Y. Molecular design for missile drug: Synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier. Makromol. Chem., 190, 2041-2054 (1989).
15. Yokoyama M, Okano T, Sakurai Y, Kataoka K, Inoue S. Stabilization of disulfide linkage in drug-polymer-immunoglobulin conjugate by microenvironmental control. Biochem. Biophys. Res. Commun., 164, 1234-1239 (1989).
16. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. Polymer micelle as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. J. Contr. Rel., 11, 269-278 (1990).
17. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res., 50, 1693-1700 (1990).
18. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res., 51, 3229-3236 (1991).
19. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto T, Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjug. Chem., 3, 295-301 (1992).
20. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science, 263, 1600-1603 (1994).
21. Hara E, Makino A, Kurihara K, Yamamoto F, Ozeki E, Kimura S. Pharmacokinetic change of nanoparticulate formulation "Lactosome" on multiple administrations. Int. Immunopharmacol., 14, 261-266 (2012).
22. Makino A, Hara E, Hara I, Yamahara R, Kurihara K, Ozeki E, Yamamoto F, Kimura S. Control of in vivo blood clearance time of polymeric micelle by stereochemistry of amphiphilic polydepsipeptides. J. Control. Release, 161, 821-825 (2012).
23. Ishihara T, Maeda T, Sakamoto H, Takasaki N, Shigyo M, Ishida T, Kiwada H, Mizushima Y, Mizushima T. Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules, 11, 2700-2706 (2010).
24. Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Contr. Rel., 29, 17-23 (1994).
25. Rajagopal K, Mahmud A, Christian DA, Pajerowski JD, Brown AE, Loverde SM, Discher DE. Curvature-coupled hydration of semicrystalline polymer amphiphiles yields flexible worm micelles but favors rigid vesicles: polycaprolactone-based block copolymers. Macromolecules, 43, 9736-9746 (2010).
26. Hermanson GT. Bioconjugate Techniques, Academic Press, San Diego (1996).
27. Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, Boerman OC. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharmacol. Exp. Ther., 292, 1071-1079 (2000).
28. Laverman P, Carstens MG, Boerman OC, Dams ET, Oyen WJ, van Rooijen N, Corstens FH, Storm G. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther., 298, 607-612 (2001).
29. Ishida T, Ichihara M, Wang X, Kiwada H. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J. Control. Release, 115, 243-250 (2006).
30. Ishida T, Kiwada H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int. J. Pharm., 354, 56-62 (2008).
31. Gabizon A, Isacson R, Rosengarten O, Tzemach D, Shmeeda H, Sapir R. An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin. Cancer Chemother. Pharmacol., 61, 695-702 (2008).
32. Kawakami S, Opanasopit P, Yokoyama M, Chansri N, Yamamoto T, Okano T, Yamashita F, Hashida M. Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. J. Pharm. Sci., 94, 2606-2615 (2005).
33. Chansri N, Kawakami S, Yokoyama M, Yamamoto T, Charoensit P, Hashida M. Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice. Pharm. Res., 25, 428-434 (2008).
34. Okuda T, Kawakami S, Yokoyama M, Yamamoto T, Yamashita F, Hashida M. Block copolymer design for stable encapsulation of N-(4-hydroxyphenyl)retinamide into polymeric micelles in mice. Int. J. Pharm., 357, 318-322 (2008).
35. Okuda T, Kawakami S, Higuchi Y, Satoh T, Oka Y, Yokoyama M, Yamashita F, Hashida M. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles. Int. J. Pharm., 373, 100-106 (2009).
36. Satoh T, Higuchi Y, Kawakami S, Hashida M, Kagechika H, Shudo K, Yokoyama M. Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control. J. Control. Release, 136, 187-195 (2009).
37. Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N. Particle size-dependent triggering of accelerated blood clearance phenomenon. Int. J. Pharm., 362, 197-200 (2008).
38. Shiraishi K, Hamano M, Ma H, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Yokoyama M. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J. Control. Release, 165, 183-190 (2013).
39. Ma H, Shiraishi K, Minowa T, Kawano K, Yokoyama M, Hattori Y, Maitani Y. Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(l-lysine)-based polymeric micelle in mice. Pharm. Res., 27, 296-302 (2010).